Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.71 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.71 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.71 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.71 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.71 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.71 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.33.2 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.33.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.33.2 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.33.2 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.33.2 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.33.2 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.33.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.33.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.52EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.52ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.52ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.52EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.52EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.52ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.465EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.465EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.465ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.465ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.465EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.465EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.465ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.465ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.39.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.39.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.39.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.39.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.39.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.39.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.39.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.39.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EK.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EK.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EK.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EK.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.233EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.233EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.233ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.233ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used